#17,114
While things could change, right now seasonal influenza is on an early, and impressive, upswing across the nation (see map & chart below), which prompted the CDC to issue a HAN Advisory (CDC HAN #0479: Increased Respiratory Virus Activity, Especially Among Children, Early in the 2022-2023 Fall and Winter) last Friday.
Complicating matters, we are also seeing a good deal of non-influenza viral infections - particularly RSV - and of course, COVID. Hospital emergency rooms, and in some cases - ICUs - are already under pressure.
Anticipating a potentially rough `flu season', next week the CDC will hold a COCA call for clinicians on testing and treatment of influenza against the backdrop of an ongoing COVID pandemic.
These 1-hour presentations are often technical in nature, and are geared to clinicians and healthcare providers, but also may be of interest to others.
Details on attending this webinar follow, but as always, if you are unable to attend the live presentation, these (and past) videos are always archived and available for later viewing at this LINK.
2022-2023 Seasonal Influenza Testing and Treatment During the COVID-19 Pandemic
Overview
The COVID-19 pandemic disrupted influenza activity during the past two seasons. Since October 2022, influenza activity has increased, signaling an early start to the U.S. influenza season. While it is not possible to predict influenza activity or the severity of the upcoming influenza season in the United States, the Centers for Disease Control and Prevention (CDC) is preparing for co-circulation of influenza and SARS-CoV-2 viruses.
While annual influenza vaccination remains the best way to prevent influenza, antiviral medications are an essential addition to vaccination—especially in treating outpatients with suspected or confirmed influenza, people at high risk for influenza complications, those with progressive disease, and hospitalized influenza patients.
During this COCA Call, the presenter will provide an overview of CDC’s recommendations for healthcare providers about influenza diagnostics and the use of antiviral medications for the 2022-2023 influenza season, including considerations during the ongoing COVID-19 pandemic.
Presenter
Tim Uyeki, MD, MPH, MPP
Chief Medical Officer
Office of the Director
Influenza Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Call Materials
None at this time.
Call Details
When:
Tuesday, November 15, 2022,
2:00 PM – 3:00 PM ET
Webinar Link:
https://www.zoomgov.com/j/1605388275
Webinar ID: 160 538 8275
Passcode: 620862
Telephone:
US: +1 669 254 5252 or +1 646 828 7666 or +1 669 216 1590 or +1 551 285 1373
One-tap mobile:
US: +16692545252,,1605388275#,,,,*620862# or +16468287666,,1605388275#,,,,*620862#
International numbersAdd to Calendar
